Skip to content

RESPIRERX PHARMACEUTICALS INC.: filings

Every RESPIRERX PHARMACEUTICALS INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 51 filings, each linked to its SEC index.

Filing record ends 2023-11-17

The latest filing in this captured record is a 10-Q filed 2023-11-17. No later filing is in the SEC companyfacts record captured on 2026-09-22. RESPIRERX PHARMACEUTICALS INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-11-17fiscal Q3 202324820001493152-23-041875
10-Q2023-08-21fiscal Q2 202324780001493152-23-029607
10-Q2023-05-22fiscal Q1 202322470001493152-23-018545
10-K2023-04-17fiscal FY 202223460001493152-23-012542
10-Q2022-11-17fiscal Q3 202221670001493152-22-032757
10-Q2022-08-22fiscal Q2 202222650001493152-22-023726
10-Q2022-05-23fiscal Q1 202224480001493152-22-014786
10-K2022-04-15fiscal FY 202122460001493152-22-010053
10-Q2021-11-15fiscal Q3 202122670001493152-21-028342
10-Q2021-08-16fiscal Q2 202119560001493152-21-020133
10-Q2021-05-24fiscal Q1 202117360001493152-21-012652
10-K2021-04-15fiscal FY 202019390001493152-21-008869
10-Q2020-11-23fiscal Q3 202018590001493152-20-022327
10-Q2020-08-19fiscal Q2 202017540001493152-20-016297
10-Q2020-05-20fiscal Q1 202017370001493152-20-009546
10-K2020-04-14fiscal FY 201918370001493152-20-006358
10-Q2019-11-19fiscal Q3 201918590001493152-19-018014
10-Q2019-08-14fiscal Q2 201917540001493152-19-012562
10-Q2019-05-20fiscal Q1 201917410001493152-19-007878
10-K2019-04-16fiscal FY 201820410001493152-19-005477
10-Q2018-11-16fiscal Q3 201821590001493152-18-016366
10-Q2018-10-15fiscal Q2 201821580001493152-18-014483
10-Q2018-05-21fiscal Q1 201821440001493152-18-007566
10-K2018-04-17fiscal FY 201723470001493152-18-005325
10-Q2017-11-20fiscal Q3 201722630001493152-17-013568
10-Q2017-08-14fiscal Q2 201721610001493152-17-009093
10-Q2017-05-19fiscal Q1 201722460001493152-17-005623
10-K2017-03-31fiscal FY 201624480001493152-17-003145
10-Q2016-11-14fiscal Q3 201624640001493152-16-015092
10-Q2016-08-12fiscal Q2 201624640001493152-16-012262
10-Q2016-05-13fiscal Q1 201624490001493152-16-009771
10-K2016-03-29fiscal FY 201524490001493152-16-008331
10-Q2015-11-12fiscal Q3 201524640001493152-15-005352
10-Q2015-08-13fiscal Q2 201523650001493152-15-003599
10-Q2015-08-07fiscal Q1 201524490001493152-15-003475
10-Q2015-05-14fiscal Q1 201523480001493152-15-001912
10-K2015-03-30fiscal FY 201423440001493152-15-001071
10-Q2015-03-09fiscal Q3 201422590001493152-15-000766
10-Q2015-02-24fiscal Q2 201422590001493152-15-000645
10-Q2015-02-10fiscal Q1 201423430001493152-15-000434
10-K2015-01-06fiscal FY 201321400001493152-15-000058
10-Q2014-12-15fiscal Q3 201321540001493152-14-004144
10-Q2014-12-15fiscal Q2 201321540001493152-14-004143
10-Q2014-11-24fiscal Q1 201320410001493152-14-003920
10-K2014-10-14fiscal FY 201228510001493152-14-003313
10-Q2014-07-30fiscal Q3 201226680001493152-14-002330
10-Q2012-08-16fiscal Q2 201222590001193125-12-359062
10-Q2012-05-15fiscal Q1 201221430001193125-12-234472
10-K2012-03-30fiscal FY 201127530001193125-12-143643
10-Q2011-11-14fiscal Q3 201125660001193125-11-310818
10-Q2011-08-18fiscal Q2 201125650001193125-11-226494

Inspect the source

Entity
RESPIRERX PHARMACEUTICALS INC. / CIK 0000849636
Captured
SEC response SHA-256
f692532c7d166963e2fad68da28689f5b935e4c0402c22ccfa62bc8615c926ab

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000849636.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))